Lyka Labs Limited (NSE:LYKALABS)
India · Delayed Price · Currency is INR 66.55
-1.72 (-2.52%)
Jun 23, 2026, 3:29 PM IST
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 2.44 billion as of June 23, 2026. Its market cap has decreased by -42.77% in one year.
Market Cap
2.44B
Enterprise Value
2.90B
Revenue
1.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
66.55
Market Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 2.44B, an increase of 727.01%. That is a compound annual growth rate of 9.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 2.44B | -10.04% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 672.43B |
| Anthem Biosciences | 444.26B |
| OneSource Specialty Pharma | 184.42B |
| Concord Biotech | 137.58B |
| Blue Jet Healthcare | 88.92B |
| Supriya Lifescience | 75.03B |
| Zota Health Care | 45.29B |
| Panacea Biotec | 32.85B |